-
Ferring acquires LYSTEDA™ from Xanodyne Pharmaceuticals, Inc.
-Ferring Pharmaceuticals today announced an agreement that will expand its Women’s Health product portfolio with the acquisition of the global rights to Xanodyne Pharmaceutical’s LYSTEDA™…
0
Archive for May, 2010
2010 > May